Mode VC
Maryland

Epidarex Capital

Epidarex Capital, based in Maryland, backs Seed and Series A life sciences and healthtech firms, typically following other investors, with a latest fund over $145 million.

Website
Entry stageSeed, Series A
Check sizen/a
Leads roundsMostly follows
FocusLife sciences, Healthtech
Latest fund>$145M>$145M Fund IV (first close; 2026-01-27)
Investing team9 peopleNo activity since Sep

Who you would pitch at Epidarex Capital

9 people on the investing team, 6 of them partners who can make the call. Partners are listed first.

Elizabeth Roper
Elizabeth RoperManaging PartnerShe focuses on early-stage life science companies and has held various directorships.
Kyparissia Sirinakis
Kyparissia SirinakisFounding PartnerShe co-founded the firm and previously led investments at MASA Life Science Ventures and founded WomenAngels.net.
Peter Finan
Peter FinanManaging PartnerHe currently serves as Managing Partner at Epidarex Capital and sits on multiple biotech boards.
Sinclair Dunlop
Sinclair DunlopManaging PartnerHe founded MASA Life Science Ventures and serves on several boards.
Lori Krim Gough
Lori Krim GoughPartnerShe is a Partner at Epidarex Capital and serves on multiple boards.
Mary Canning
Mary CanningPartnerShe previously worked at MRC Technology and Scottish Enterprise, and holds a Ph.D. from the University of Edinburgh.
Matthew Miessau
Matthew MiessauPrincipalHe previously managed the Georgetown University Center for Drug Discovery and teaches at the NIH Foundation for Advanced Education in the Sciences.
Melissa Lezameta
Melissa LezametaSenior Associate
Victor Pong
Victor PongAssociateHe previously worked as a Life Sciences Specialist at L.E.K.

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

How to reach them[email protected]

Notable investments

Apellis PharmaceuticalsNodTheraEpsilogenEdinburgh Molecular ImagingEnterprise TherapeuticsAdoRx TherapeuticsCaldan Therapeutics
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Epidarex Capital is active

One email when this firm shows new activity. Nothing else.

Firms like Epidarex Capital

Northpond Ventures$1M to $3M
Hitachi Ventures$1M to $30M · active Oct 15
Narya Capital$3M to $10M · active Sep 29
The Engine$250K to $10M · active Sep 22
Arkitekt VenturesCheck size not reported
Artis Ventures (AV)Check size not reported

On these lists

Seed investors in United States2836Series A investors in United States1790Seed healthtech investors287Series A healthtech investors243Seed life sciences investors186Series A life sciences investors167Seed investors in Maryland10Seed investors3020

Questions

What stage does Epidarex Capital invest in?

Epidarex Capital reports entry at seed, series a.

How much does Epidarex Capital invest?

Epidarex Capital has not reported a check size.

Does Epidarex Capital lead rounds?

Epidarex Capital mostly follows other investors.

Who are the partners at Epidarex Capital?

Elizabeth Roper (Managing Partner), Kyparissia Sirinakis (Founding Partner), Peter Finan (Managing Partner), Sinclair Dunlop (Managing Partner), Lori Krim Gough (Partner), Mary Canning (Partner).

Is Epidarex Capital active right now?

No recent activity since September 2026.

Work at Epidarex Capital? Claim or correct this profile.